Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sinapultide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105384799A details a hybrid solid-liquid phase synthesis for sinapultide. This method offers high purity and cost reduction in peptide manufacturing.
Patent CN104817631B reveals improved peptide synthesis yielding high purity. Offers cost reduction and supply reliability for respiratory drug manufacturing.